Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

Treatment for two weeks with either oral prednisolone (30 mg/day), high dose fluticasone propionate (2000 μg/day, FP2000), or lower dose FP (500 μg/day, FP500), both given by a dry powder inhaler, ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol ... In addition, prior ...

Each spray delivers 93 micrograms (mcg) of the active ... Certain inhaler medications are used to treat asthma and contain the active drug fluticasone propionate. Xhance contains the same active ...

Patients had mild to moderately severe COPD (FEV 1 25–80% of predicted) and were given 3 months treatment with ICS, fluticasone propionate (FP; 500 μg twice daily, n=14) or placebo (n=10). Biopsy ...

Results The study cohort included 20 388 propensity score matched pairs of new users initiating single inhaler triple therapy ... In addition, prior observational studies comparing budesonide and ...

Massachusetts families are still struggling to find alternatives about a year after GlaxoSmithKline canceled a widely prescribed children’s asthma medication, a problem given renewed urgency as ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

The other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a. In a 2024 JAMA report ...

If your inhaler has a dose counter, this eliminates all the guesswork and uncertainty about how much medicine is left in an inhaler. For example, Ventolin HFA, Advair HFA, and fluticasone have dose ...